Home > Healthcare > Pharmaceuticals > Finished Drug Form > Sodium Hyaluronate-based Products Market

Sodium Hyaluronate-based Products Market Share

Report ID: GMI8374
Published Date: Mar 2024
Report Format: PDF

Download Free Sample

Sodium Hyaluronate-based Products Market Share

The sodium hyaluronate-based products industry is competitive in nature, with several large multinationals, small and mid-sized companies competing in the industry. The development and launch of novel advanced products based on different technologies is among a key market strategy. Some of the leading industry players including ASHLAND INC., Allergan, Inc., Anika Therapeutics, Inc, GALDERMA, Zimmer Biomet, among others have a notable presence in the market.

Sodium Hyaluronate-based Products Market Companies

Some of the eminent market participants operating in the sodium hyaluronate-based products industry include:

ASHLAND INC.
Allergan, Inc.
Anika Therapeutics, Inc
Bohus BioTech AB
Cadila Pharmaceuticals
Ferring B.V.
Fidia Farmaceutici S.p.A.
GALDERMA
LG Chem, Ltd.
Syner-Med (Pharmaceutical Products) Ltd.
Zimmer Biomet

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global sodium hyaluronate-based products industry size was valued at USD 11.3 billion in 2023 and is estimated to reach over USD 22.7 billion by 2032, attributed to various factors, including the ongoing advancements in formulation technologies, and rising demand for anti-aging products.

Injectable sodium hyaluronate-based products industry garnered USD 9.7 billion in revenue in 2023 and is set to grow rapidly by 2032, owing to their convenience, safety, and relatively low risk.

North America sodium hyaluronate-based products industry size was USD 4.5 billion in 2023 and is predicted to witness substantial growth till 2032 driven by the thriving skincare & cosmetic sector, characterized by product innovation, technological advancements, and consumer-driven trends.

ASHLAND INC., Allergan, Inc., Anika Therapeutics, Inc, Bohus BioTech AB, Cadila Pharmaceuticals, Ferring B.V., Fidia Farmaceutici S.p.A., GALDERMA, LG Chem, Ltd., Syner-Med (Pharmaceutical Products) Ltd. are some of the major industry contenders.